Accessibility Menu
 
Oxford BioDynamics Plc logo

Oxford BioDynamics Plc

(LSE) OBD

Current Price$0.20
Market Cap$815.27M
Since IPO (2016)-100%
5 Year-100%
1 Year-55%
1 Month-24%

Oxford BioDynamics Plc Financials at a Glance

Market Cap

$815.27M

Revenue (TTM)

$1.73M

Net Income (TTM)

$22.72M

EPS (TTM)

$-0.95

P/E Ratio

-0.20

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.20

Volume

7,505,455

Open

$0.20

Previous Close

$0.20

Daily Range

$0.18 - $0.22

52-Week Range

$0.18 - $0.78

OBD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford BioDynamics Plc

Industry

Life Sciences Tools and Services

CEO

Jon Burrows, PhD

Headquarters

Oxford, OX4 2WB, GB

OBD Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-10%

Net Income Margin

-10%

Return on Equity

-407%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-5.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$815.27M

Shares Outstanding

4.29B

Volume

7.51M

Short Interest

0.00%

Avg. Volume

17.44M

Financials (TTM)

Gross Profit

$6.15M

Operating Income

$10.66M

EBITDA

$9.80M

Operating Cash Flow

$7.71M

Capital Expenditure

$17.00K

Free Cash Flow

$7.73M

Cash & ST Invst.

$1.39M

Total Debt

$5.11M

Oxford BioDynamics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$508.00K

+75.2%

Gross Profit

$3.07M

+15.1%

Gross Margin

-6.05%

N/A

Market Cap

$815.27M

N/A

Market Cap/Employee

$15.99M

N/A

Employees

51

N/A

Net Income

$5.40M

+15.4%

EBITDA

$4.76M

+17.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.72M

-212.8%

Accounts Receivable

$694.00K

-57.8%

Inventory

$195.00K

-28.8%

Long Term Debt

$3.82M

-32.0%

Short Term Debt

$1.29M

+57.5%

Return on Assets

-1.38%

N/A

Return on Invested Capital

-1.95%

N/A

Free Cash Flow

$2.78M

+23.1%

Operating Cash Flow

$2.76M

+12.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CIZ.LCizzle Biotechnology Holdings Plc
$2.35-2.08%
OPTI.LOptiBiotix Health Plc
$5.45+3.81%
GDR.LGenedrive Plc
$0.95+0.00%
TRX.LTissue Regenix Group plc
$7.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About OBD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.